Valmark Advisers’s DermTech, Inc. Common Stock DMTK Stock Holding History

Valmark Advisers’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,470	Closed	-$82.7K	–	494
2023 Q1	$82.7K	Hold	22,470	–	–	﹤0.01%	472
2022 Q4	$39.8K	Buy	+22,470	New	+$59.8K	﹤0.01%	441

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Valmark Advisers's DMTK Position: Q2 2023 in Review

Valmark Advisers sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 22,470 shares — an estimated $82.7K sold.

Valmark Advisers first reported a position in DMTK in Q4 2022 and held it in 2 quarters. The position peaked at $82.7K in Q1 2023. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

Valmark Advisers reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Valmark Advisers sold 22,470 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $82.7K.
Valmark Advisers first reported a position in DermTech, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Valmark Advisers's DermTech, Inc. Common Stock position peaked at $82.7K in Q1 2023.
85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Valmark Advisers's 13F filing for Q2 2023, filed 3 Aug 2023.